Shares of Prestige Consumer Healthcare Inc (NYSE:PBH) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $57.88.
A number of equities research analysts recently weighed in on the stock. Zacks Investment Research raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a research report on Wednesday, January 2nd. Raymond James lowered shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 target price for the company. in a research note on Tuesday, January 15th. Royal Bank of Canada reissued a “buy” rating and set a $97.00 target price on shares of Prestige Consumer Healthcare in a research note on Friday, March 15th. Desjardins lowered shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 target price for the company. in a research note on Wednesday, February 13th. Finally, ValuEngine lowered shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a research note on Thursday, January 10th.
NYSE PBH traded down $0.01 during midday trading on Monday, hitting $28.07. 20,580 shares of the company traded hands, compared to its average volume of 601,188. The company has a current ratio of 2.28, a quick ratio of 1.34 and a debt-to-equity ratio of 1.49. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The stock has a market capitalization of $1.45 billion, a PE ratio of 10.88, a price-to-earnings-growth ratio of 1.58 and a beta of 0.98.
Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.02. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The business had revenue of $241.40 million during the quarter, compared to the consensus estimate of $241.40 million. During the same quarter in the prior year, the firm earned $0.70 EPS. The company’s revenue for the quarter was down 10.8% compared to the same quarter last year. On average, equities analysts predict that Prestige Consumer Healthcare will post 2.77 earnings per share for the current fiscal year.
A number of institutional investors have recently bought and sold shares of PBH. Thrivent Financial for Lutherans lifted its stake in shares of Prestige Consumer Healthcare by 2.7% in the 4th quarter. Thrivent Financial for Lutherans now owns 13,137 shares…